UFP Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
UFP Technologies, Inc. (UFPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.30% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-02-27
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.30%.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.90%, a 262.50% increase from fiscal 2021.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.80%, a 0.00% change from fiscal 2020.
- UFP Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.80%, a 65.22% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 4.30% 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | 4.30% 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 4.30% 10-Q · filed 2024-08-09 | ||||
| 2022-12-31 | 2.90% 10-K · filed 2025-03-03 | ||||
| 2022-06-08 | 2.90% 10-Q/A · filed 2022-11-14 | ||||
| 2021-12-31 | 0.80% 10-K · filed 2023-03-16 | ||||
| 2021-06-09 | 0.80% 10-Q · filed 2021-11-05 | ||||
| 2020-12-31 | 0.80% 10-K · filed 2024-02-29 | 0.30% 10-K · filed 2021-03-12 | |||
| 2020-06-10 | 0.30% 10-Q · filed 2020-11-06 | ||||
| 2019-12-31 | 2.30% 10-K · filed 2022-03-14 | ||||
| 2019-09-30 | 2.30% 10-Q · filed 2019-11-08 | ||||
| 2019-06-30 | 2.30% 10-Q · filed 2019-08-09 | ||||
| 2018-12-31 | 2.70% 10-K · filed 2021-03-12 | ||||
| 2017-06-06 | 1.84% 10-Q · filed 2017-08-09 | ||||
| 2016-09-30 | 0.90% 10-Q · filed 2016-11-09 | ||||
| 2016-06-09 | 0.90% 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |